Organ transplantation in rodents: Novel applications of long-established methods

Transplant Immunology

Volumn 18, Issue 1, 2007, Pages 44-52

  Boros, Peter ^a   Liu, Jianhua ^a   Li, Yansui ^a   Bromberg, Jonathan S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Experimental transplantation; Gene therapy; Microsurgery; Rodents

Indexed keywords

ALLOIMMUNITY; BIOTECHNOLOGY; GENETIC ENGINEERING; INNATE IMMUNITY; LIVER REGENERATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RODENT; SURGICAL TECHNIQUE; SURVIVAL RATE;

ANIMALS; CELL MOVEMENT; FETAL TISSUE TRANSPLANTATION; GENE THERAPY; GENETIC ENGINEERING; IMMUNITY, NATURAL; ISCHEMIC PRECONDITIONING; LEUKOCYTES; MICE; MODELS, ANIMAL; ORGAN PRESERVATION SOLUTIONS; ORGAN TRANSPLANTATION; RATS; REGENERATION;

EID: 34250320139     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.03.004     Document Type: Review

References (50)

1. Ambiru L., Uryuhara K., Talpe S., Dehoux J.P., Jacobbi L., Murphy C.J., et al. Improved survival of orthotopic liver allograft in swine by addition of trophic factors to University of Wisconsin solution. Transplantation 77 (2004) 302-319
2. Vajdova K., Graf R., and Clavien P.A. ATP-supplies in the cold-preserved liver: a long-neglected factor of organ viability. Hepatology 36 (2002) 1543-1552
3. Li X.L., Man K., Liu Y.F., Lee T.K., Tsui S.H., Lau C.K., et al. Insulin in University of Wisconsin solution exacerbates the ischemic injury and decreases the graft survival rate in rat liver transplantation. Transplantation 76 (2003) 44-49
4. Moresco R.N., Santos R.C., Alves Filho J.C., Cunha A.A., dos Reis C., Reichel C.L., et al. Protective effect of fructose-1,6-bisphosphate in the cold storage solution for liver preservation in rat hepatic. Transplant Proc 36 (2004) 1261-1264
5. Carrasco-Chaumel E., Rosello-Catafau J., Bartrons R., Franco-Gou R., Xaus C., Casillas A., et al. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 43 (2005) 997-1006
6. Buehler A., Martire A., Strohm C., Wolfram S., Fernandez B., Palmen M., et al. Angiogenesis-independent cardioprotection in FGF-1 transgenic mice. Cardiovasc Res 55 (2002) 768-777
7. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase [RISK]-pathway. Cardiovasc Res 61 (2004) 448-460
8. * represses Bim expression independently of the JNK or PI3K pathways. Oncogene 22 (2003) 1281-1293
9. van der Wuede F.J., Schnuelle P., and Tard B.A. Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J Investig Med 52 (2004) 323-329
10. Carinin R., and Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 (2003) 1480-1491
11. Nicolls M.R., Columbe M., and Gill G.R. The basis of immunogenicity of endocrine allografts. Crit Rev Immunol 21 (2001) 87-101
12. Benhamou P.Y., Stein E., Hover C., Miyamoto M., Watanabe Y., Nomura Y., et al. Ultraviolet light irradiation reduces human islet immunogenicity without altering islet function. Horm Metab Res 27 (1995) 113-120
13. Sung R.S., Fiedor P.S., Yaron I., Zakhein A.R., Quadracci K.M., Goodman E.R., et al. Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. Transplant Proc 28 (1996) 839
14. Cobbolds S.P., Nolan K.F., Graca L., Castejon R., Le Moine A., Frewin M., et al. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 196 (Dec 2003) 109-124
15. Coito A.J., Buelow R., Shen X.D., Amersi F., Moore C., Volk H.D., et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion.injury. Transplantation 74 (2002) 96-102
16. Wang X.H., Wang K., Zhang F., Li X.C., Li D., De W., et al. Heme oxygenase-1 alleviates ischemia/reperfusion injury in aged liver. World J Gastroenterol 11 (2005) 690-694
17. Ke B., Shen X.D., Lassman C.R., Gao F., Busuttil R.W., and Kupiec-Weglisnki J.W. Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion. Transplantation 75 (2003) 1118-1123
18. Yamasita K., Masanuga T., Yanagi N., Takehara M., Hashimoto T., Kobayashi T., et al. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies. Transplantation 76 (2003) 1089-1096
19. Hua N., Yamashita K., Hashimoto T., Masanuga T., Fujita M., Furukawa H., et al. Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft antibody suppression induces long-term acceptance of cardiac xenografts. Transplantation 78 (2004) 1463-1470
20. Tomasni S., Aiello S., Cassis L., Noris M., Longaretti L., Cavinatto R.A., et al. Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. Transplantation 79 (2005) 1056-1061
21. Matsue H., Matsue K., Walters M., Okumura K., Yagita H., and Takashima A. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells. Nat Med 8 (1999) 930-937
22. Geissler E.K., Scherer M.N., Graeb C., Cao Y.A., Yang Y., and Caffarelli A.D. Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model. Transpl Int 1 (2000) S452-S455
23. DeVries M.E., Ran L., and Kelvin D.J. On the edge: the physiological and pathophysiological role of chemokines during inflammatory and immunological responses. Semin Immunol 11 (1999) 95-104
24. Stievano L., Piovan E., and Amadori A. C and CX3C chemokines: cell sources and physiopathological implications. Crit Rev Immunol 24 (2004) 205-228
25. Tanaka M., Swinenburg R.J., Gunawan F., Cao Y.A., Yang Y., Caffarelli A.D., et al. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation 112 (2005) 105-110
26. Kanderi T., Moore W.H., and Wendt J.A. Molecular imaging in transplantation: basic concepts and strategies for potential application. Nucl Med Commun 11 (2005) 947-955
27. Olthoff K.M. Molecular pathways of regeneration and repair after liver transplantation. World J Surg 7 (2002) 831-837
28. Tian Y., Jochum W., Geogiev P., Moritz W., Graf R., and Clavien P.A. Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse. Proc Natl Acad Sci U S A 103 (2006) 4598-4603
29. Price P.M., Megyesi J., and Safirstein R.L. Cell cycle regulation: Repair and regeneration in acute renal failure. Kidney Int 66 (2004) 509-514
30. Penn M.S., Zhang M., Deglurkar I., and Topol E.J. Role of stem cell homing in myocardial regeneration. Nat Med 9 (2003) 1370-1376
31. Dekel B., Zangi L., Shezen E., Reich-Zeliger S., Eventov-Friedman S., Katchman H., et al. Isolation and characterization of nontubular Sca-1 + Lin-multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 17 (2006) 3300-3314
32. Fougere-Deschatrette C., Imaizumi_Scherrer T., Stick-Marchand H., Morosan S., Charneau P., Kremsdorf D., et al. Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells 24 (2006) 2098-2109
33. Franco-Gou R., Peralta C., Massip-Salcedo M., Xaus C., Serafín A., and Rosello-Catafau J. Protection of reduced-size liver for transplantation. Am J Transplant 4 (2004) 1408-1420
34. Ramalho F.S., Ramalho L.N., Castro-e-Silva Junior O., Zucoloto S., and Correa F.M. Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats. Hepatogastroenterology 49 (2002) 1347-1351
35. Araya J., Tsuruma T., Hirata K., Yagihashi A., and Watanabe N. TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats. Transplantation 73 (2002) 529-534
36. Rezai N., Podor T.J., and McManus B.M. Bone marrow-derived recipient cells in murine transplanted hearts: potential roles and the effect of immunosuppression. Lab Invest 85 (2005) 982-991
37. Tang Y.L., Qian K., Zhang Y.C., Shen L., and Phillips M.I. Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha [SDF-1alpha] treatment. Regul Pept 125 (2005) 1-8
38. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ichling K., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9 (2003) 1370-1376
39. Peng Y., Gong J.P., Liu C.A., Li X.H., Gan L., and Li S.B. Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J Gastroenterol 10 (2004) 2890-2903
40. Wu H.S., Zhang J.X., Wang L., Tian Y., Wang H., and Rotstein O. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 3 (2004) 250-253
41. Fondevila C., Busuttil R.W., and Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury - a fresh look. Exp Mol Pathol 74 (2003) 86-93
42. Zhai Y., Shen X.D., O'Connell R., Gao F., Lassman C., Busuttil R.W., et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFNγ regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (2004) 7115-7119
43. Tsan M.F., and Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 76 (2004) 514-519
44. Beg A.A. Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol 23 (2002) 509-512
45. Loi P., Paulart F., Pajak B., Nagy N., Salmon I., Moser M., et al. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant Proc 36 (2004) 1275-1279
46. Samstein B., Johnson G.B., and Platt J.L. Toll-like receptor-4 and allograft responses. Transplantation 77 (2004) 475-487
47. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
48. Obara H., Nagasaki K., Hsieh C.L., Ogura Y., Esquivel C.O., Martinez O.M., et al. IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant 9 (2005) 2094-2103
49. Hammerman M.R. Transplantation of embryonic organs-kidney and pancreas. Am J Transplant 4 Suppl 6 (2004) 14-24
50. Hammerman M.R. Windows of opportunity for organogenesis. Transpl Immunol 1 (2005) 1-8